Compare Reddit Inc (RDDT) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

RDDT trades at $152.77, up 2.59% today, but remains in a bearish technical trend with key support at $148 and resistance at $156. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.25 surpassing the $0.949 estimate. Revenue grew to $2.20 billion in 2025, with a net income margin of 31.35%, while analyst consensus is a Buy with a $202.52 price target. Recent news includes a partnership with Zefr for advertiser insights and CEO share sales.

The outlook for RDDT is mixed; strong profitability and analyst optimism contrast with bearish technicals and competitive pressures. Investment opportunity lies in continued earnings growth and international expansion, but risks include stock volatility, AI competition, and reliance on advertising revenue. The stock's current price is 24.5% below the consensus target, suggesting potential upside if fundamentals hold.

Regeneron Pharmaceuticals (REGN) trades at $742.12, up 0.46% on the day, with a bearish technical signal despite strong fundamentals. The stock shows robust profitability with a 27.86% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights a significant $8 billion immunology alliance expansion with Sanofi, providing substantial upfront and milestone payments.

The outlook is positive due to strong earnings momentum and strategic collaborations, but risks include competitive pressures in key drug markets and technical bearish indicators. Analyst consensus is bullish with a $849.84 price target, suggesting potential upside from current levels, though investors should monitor execution of new partnerships and pipeline developments.